Domain > www.aethlonmedical.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2024-09-30	50.18.213.204 (ClassC)
2025-01-01	13.52.206.199 (ClassC)

HTTP/1.1 200 OKDate: Mon, 30 Sep 2024 13:43:38 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeatu

!DOCTYPE html>html langen>    head>        meta http-equivx-ua-compatible contentieedge>        meta charsetutf-8>                        link relalternate typeapplication/rss+xml titleAethlon Medical, Inc. - Recent News hrefhttps://www.aethlonmedical.com/news-media/press-releases/rss />                        title>Aethlon Medical, Inc. (AEMD)/title>                link relcanonical hrefhttps://www.aethlonmedical.com>meta propertyog:url contenthttps://www.aethlonmedical.com>meta propertyog:site_name contentAethlon Medical, Inc.>meta propertyog:title contentAethlon Medical, Inc.>meta propertyog:type contentwebsite>script typeapplication/ld+json>	{@context:http://schema.org,@type:Corporation,name:Aethlon Medical, Inc.,address:{@type:PostalAddress,streetAddress:11555 Sorrento Valley Road  Suite 203,addressLocality:San Diego, CA,postalCode:92121,addressCountry:},legalName:Aethlon Medical, Inc.,description:Aethlon Medical develops immunotherapeutic technologies to combat cancer and infectious disease. The Aethlon Hemopurifieru00ae is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and circulating viruses. The United States Food and Drug Administration (FDA) has designated the Hemopurifieru00ae as a u201cBreakthrough Deviceu201d for 1) the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease; and 2) life-threatening viruses that are not addressed with approved therapies.
Aethlon Medical is currently conducting a clinical trial in Sars-CoV-2 in India and are in the process of launching an oncology clinical trial in Australia.,tickerSymbol:: AEMD,url:https://www.aethlonmedical.com,logo:https://d1io3yog0oux5.cloudfront.net/_cb15afbc855e12938a6dec8fc0783dff/aethlonmedical/logo.png,image:null,sameAs:}/script>!-- Elastic Search -->          meta nameviewport contentinitial-scale1.0,

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.aethlonmedical.com

Is this malicious?

DNS Resolutions

Port 443